Literature DB >> 8404538

Ventral spinal cord inhibition of neurite outgrowth from embryonic rat dorsal root ganglia.

M Fitzgerald1, G C Kwiat, J Middleton, A Pini.   

Abstract

Organotypic culture of embryonic rat lumbar spinal cord and dorsal root ganglia has been used to demonstrate an inhibitory effect of ventral spinal cord on neurite growth from dorsal root ganglion explants. When dorsal root ganglion explants from 14-15 day old embryos were cultured alone or in close proximity to a dorsal cord explant, the pattern of dorsal root ganglion neurite outgrowth was typically radial. However, when E14-15 dorsal root ganglion explants were cocultured for 22-24 hours in proximity to a ventral spinal cord explant from the same embryo, few, if any, dorsal root ganglion neurites grew in the direction of the ventral cord explant. This inhibitory effect appeared to be developmentally regulated; it was diminished or absent in cocultures prepared from 18 day old embryos. In contrast, in cocultures of dorsal cord and ventral cord explants from E14-15 embryos, dorsal cord neurites grew abundantly toward the ventral cord explant suggesting that the inhibition is not likely to be due to a nonspecific neurotoxic effect and that the activity responsible selectively inhibits dorsal root ganglion neurite outgrowth. We conclude that a diffusible, primary afferent inhibitory factor(s) produced by embryonic ventral horn may be responsible for the inhibition. Our results are discussed with respect to the possible involvement of inhibition in the normal development of primary afferent innervation of the spinal cord.

Entities:  

Mesh:

Year:  1993        PMID: 8404538     DOI: 10.1242/dev.117.4.1377

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  9 in total

1.  A sensory neuron subpopulation with unique sequential survival dependence on nerve growth factor and basic fibroblast growth factor during development.

Authors:  C G Acosta; A R Fábrega; D H Mascó; H S López
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

2.  Coupling of nerve growth factor to its receptor: inhibition by anti-GM3 ganglioside antibody.

Authors:  M Chakraborty; D Chatterjee
Journal:  Cell Mol Neurobiol       Date:  2001-02       Impact factor: 5.046

3.  Trigeminal ganglion axons are repelled by their presumptive targets.

Authors:  M W Rochlin; A I Farbman
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

Review 4.  Development of regional specificity of spinal and medullary dorsal horn neurons.

Authors:  Yu-Feng Xie; Xing-Hong Jiang; Barry J Sessle; Xian-Min Yu
Journal:  World J Biol Chem       Date:  2016-02-26

5.  Chemoattraction and chemorepulsion of olfactory bulb axons by different secreted semaphorins.

Authors:  F de Castro; L Hu; H Drabkin; C Sotelo; A Chédotal
Journal:  J Neurosci       Date:  1999-06-01       Impact factor: 6.167

6.  Type III neuregulin 1 regulates pathfinding of sensory axons in the developing spinal cord and periphery.

Authors:  Melissa L Hancock; Dan W Nowakowski; Lorna W Role; David A Talmage; John G Flanagan
Journal:  Development       Date:  2011-11       Impact factor: 6.868

7.  A sensory axon repellent secreted from ventral spinal cord explants is neutralized by antibodies raised against collapsin-1.

Authors:  I T Shepherd; Y Luo; F Lefcort; L F Reichardt; J A Raper
Journal:  Development       Date:  1997-04       Impact factor: 6.868

8.  Targeting sensory axon regeneration in adult spinal cord.

Authors:  Xiao-Qing Tang; Paula Heron; Charles Mashburn; George M Smith
Journal:  J Neurosci       Date:  2007-05-30       Impact factor: 6.167

9.  A robust and reproducible human pluripotent stem cell derived model of neurite outgrowth in a three-dimensional culture system and its application to study neurite inhibition.

Authors:  Kirsty E Clarke; Daniel M Tams; Andrew P Henderson; Mathilde F Roger; Andrew Whiting; Stefan A Przyborski
Journal:  Neurochem Int       Date:  2016-12-21       Impact factor: 3.921

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.